Pfizer recently recognized the Hutchinson Clinic Clinical Trials team as one of the top 5 enrollers in the Spire trials, which involve a new medication to treat high cholesterol. There are two Spire trials that have a combined 3,176 sites active worldwide, with nearly 14,000 patients currently enrolled. The combined enrollment goal for both trials is 27,000. The Hutchinson Clinic has screened nearly 140 people with approximately 60 actively participating in the trial. The Hutch Clinic is still seeking trial participants. You may qualify if you are at least 18, and are taking medication to treat your high cholesterol. For more information about the trial, visit www.mycholesterolstudy.com, or call Juan Morales at 620-694-4123.